Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

Vaccine
D P GreenbergLuwy Musey

Abstract

Pediatric use of pneumococcal conjugate vaccines (PCV) has been associated with significant decrease in disease burden. However, disease caused by non-vaccine serotypes has increased. Safety and immunogenicity of 15-valent PCV (PCV15) containing serotypes included in 13-valent PCV (PCV13) plus serotypes 22F and 33F were evaluated in infants (NCT01215188). Infants received adjuvanted PCV15, nonadjuvanted PCV15, or PCV13 at 2, 4, 6, and 12-15 months of age. Safety was monitored for 14 days after each dose. Serotype-specific IgG geometric mean concentrations (GMCs) and opsonophagocytic activity (OPA) geometric mean titers (GMTs) were measured at postdose-3, predose-4, and postdose-4. Safety profiles were comparable across vaccination groups. At postdose-3, both PCV15 formulations were non-inferior to PCV13 for 10 of 13 shared serotypes but failed non-inferiority for 3 serotypes (6A, 6B, and 19A) based on proportion of subjects achieving IgG GMC ≥0.35 µg/mL. Adjuvanted PCV15 and nonadjuvanted PCV15 were non-inferior to PCV13 for 11 and 8 shared serotypes, respectively, based on postdose 3 comparisons of GMC ratios. PCV15 induced higher antibodies to serotypes 3, 22F, and 33F than PCV13. PCV15 displayed acceptable safety profile and...Continue Reading

Citations

Aug 2, 2019·PloS One·Mark van der LindenStephanie Perniciaro
Jul 5, 2019·Expert Opinion on Investigational Drugs·Nicola Principi, Susanna Esposito
Nov 23, 2019·Diagnostics·María Del Mar García-SuárezEnrique Santiago
Nov 15, 2019·The Pediatric Infectious Disease Journal·Jinfu XieJulie M Skinner
Jan 7, 2020·Expert Review of Vaccines·T R ConversoL C C Leite
Jun 13, 2020·Human Vaccines & Immunotherapeutics·Mehmet CeyhanYasemin Ay Altintop
Apr 28, 2020·Clinical and Experimental Pediatrics·Jin Lee
May 16, 2020·F1000Research·Charles Feldman, Ronald Anderson
Nov 2, 2019·Infectious Disease Clinics of North America·Deirdre Fitzgerald, Grant W Waterer
Feb 3, 2020·International Journal of Pediatric Otorhinolaryngology·Regie Lyn P Santos-CortezGarth D Ehrlich
Mar 16, 2021·Vaccine·Zahin Amin-ChowdhuryShamez N Ladhani
Apr 26, 2021·Infectious Diseases and Therapy·Amgad GamilAngelica M Claveria
Jun 22, 2021·American Journal of Preventive Medicine·Kenneth J SmithRichard K Zimmerman
Jul 1, 2021·Diagnostic Microbiology and Infectious Disease·Alyssa R GoldenUNKNOWN Canadian Antimicrobial Resistance Alliance (CARA)
Jul 19, 2021·Microbial Pathogenesis·Lazara Elena Santiesteban-LoresEneas Carvalho

❮ Previous
Next ❯